TAT Honorary Award Lecture
Dr. Anthony Tolcher has been awarded the TAT Honorary Award Lecture 2016. He will present the lecture under the title ““Disrupting Early Clinical Trials” in the TAT 2016 Opening Ceremony.
The TAT 2016 Program Committee recognizes that some exciting research data were not available by the general abstract submission deadline. Hence, we offer the opportunity to submit late-breaking abstracts (LBA) for abstracts that highlight novel and substantive studies of significant impact. LBAs are welcome until February 22, midnight CET.
Preview TAT 2016
Symposium President Giuseppe Giaccone gives a preview of TAT 2016 in Washington DC, March 21-23 2016: early-phase development of innovative targeted and immunological agents.
Near-final program available
The near-final program of TAT 2016 is online now. View the topics that will be covered at TAT 2016 and confirmed speakers’ names. Updated regularly!
Register now to secure your participation in one of the leading meetings on emerging innovations in systemic cancer therapy.
Exhibitor & Support Opportunities
Act now to identify the best strategies at TAT 2016 to get the RESULTS your company expects in this dynamic marketplace.
Meet global phase 1 leaders
Expand your network with global leaders in early-phase drug development at TAT 2016. Many leading phase 1 investigators and translational research scientists are confirmed speakers or session chairs.